Defining the action spectrum of potential PGC-1α activators on a mitochondrial and cellular level in vivo.
about
Biosynthesis, remodeling and turnover of mitochondrial cardiolipinPhenotypic rescue of a Drosophila model of mitochondrial ANT1 disease.Early-Life Exposure to Lead Induces Cognitive Impairment in Elder Mice Targeting SIRT1 Phosphorylation and Oxidative Alterations.MTO1 mediates tissue specificity of OXPHOS defects via tRNA modification and translation optimization, which can be bypassed by dietary intervention.Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway.Loss of protein association causes cardiolipin degradation in Barth syndrome.Early effects of the antineoplastic agent salinomycin on mitochondrial function.Peroxisome proliferator-activated receptor-γ-coactivator 1α (PGC-1α) gene expression in chronic kidney disease patients on hemodialysis: relation to hemodialysis-related cardiovascular morbidity and mortality.Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.Mitochondrial protein acetylation mediates nutrient sensing of mitochondrial protein synthesis and mitonuclear protein balance.
P2860
Q28395064-81A7A0BB-8CED-41FC-9E10-9D59CF88713AQ30579069-058FFA09-CF42-4697-9478-388676F5E7ABQ33849789-61CD0DEA-B7D7-47D1-8521-12AA67D550DCQ35234097-4FB29721-B51B-453B-9375-993D0EB8319BQ35882559-DA7E4C12-A5C7-472F-AF87-25D99776A9FFQ37114282-C0CAFE90-CBD7-4149-9724-B4E5D0A7965DQ43189326-29A892D6-880C-471D-B1D0-51D3E190AFF4Q46436371-6620295D-8424-45EF-B767-1B433ECBDF48Q47988632-1F03E501-E92A-4A81-93D5-D27C920D9CC0Q54184938-8B47F0B3-16B2-43F9-9F48-0B0E5AD1D87D
P2860
Defining the action spectrum of potential PGC-1α activators on a mitochondrial and cellular level in vivo.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Defining the action spectrum o ...... al and cellular level in vivo.
@en
Defining the action spectrum o ...... al and cellular level in vivo.
@nl
type
label
Defining the action spectrum o ...... al and cellular level in vivo.
@en
Defining the action spectrum o ...... al and cellular level in vivo.
@nl
prefLabel
Defining the action spectrum o ...... al and cellular level in vivo.
@en
Defining the action spectrum o ...... al and cellular level in vivo.
@nl
P2093
P2860
P356
P1476
Defining the action spectrum o ...... al and cellular level in vivo.
@en
P2093
Annette Hofer
Astrid Schauß
Christin Tischner
Natalie Noe
Nikolay Kladt
Veronika Lellek
P2860
P304
P356
10.1093/HMG/DDT631
P577
2013-12-13T00:00:00Z